Colombet I, Sabatier B, Gillaizeau F, Prognon P, Begué D, Durieux P
INSERM, UMR_S 872, Paris, France.
Qual Saf Health Care. 2009 Jun;18(3):232-5. doi: 10.1136/qshc.2007.023887.
Drugs are often given intravenously even when the patient is able to swallow and when an oral form would be more cost-effective.
Evaluation of the impact of a multifaceted intervention on the early switch from intravenous to oral administration of proton pump inhibitors (PPI) in a hospital setting. The interrupted time series of intravenous PPI consumption was analysed.
At a French University Hospital, the Drug Committee, composed of multidisciplinary pharmacy and medical staff, addressed the issue of increasing consumption of intravenous PPI drugs (May 2003).
Letters to department heads, academic analyses from members of the Drug Committee, paper reminders at the point of care and audit-feedbacks by pharmacists. Monitoring of consumption and repeated reminder letters were planned. EFFECT OF CHANGE: The consumption of PPI was stable before the first intervention (mean level: 954 units/month). An immediate decrease occurred after the first Drug Committee letter (30% relative reduction, 95% CI -16% to -46%; p<0.001) with a significant trend change during the first multifaceted intervention (-24 units/month, 95% CI -42 to -7; p = 0.007). After the end of the outreach visits (July 2004), the consumptions increased (+32 units/month, 95% CI: 14 to 50, p<0.001). The second intervention had no significant impact.
A complex intervention (audit, feedbacks, outreach visits) had an effect on practice. It was not sustained even after a less resource-intensive intervention. Other types of interventions are needed that could be continuously implemented to improve ordering practices long term.
即便患者能够吞咽且口服剂型更具成本效益,药物通常仍通过静脉注射给药。
评估多方面干预措施对医院环境中质子泵抑制剂(PPI)从静脉给药尽早转换为口服给药的影响。分析了静脉注射PPI消耗量的中断时间序列。
在一家法国大学医院,由多学科药学和医务人员组成的药物委员会于2003年5月着手解决静脉注射PPI药物消耗量增加的问题。
致各科室主任的信函、药物委员会成员的学术分析、护理点的纸质提醒以及药剂师的审核反馈。计划对消耗量进行监测并发出重复提醒信函。
在首次干预前,PPI的消耗量稳定(平均水平:954单位/月)。在药物委员会发出第一封信函后,消耗量立即下降(相对减少30%,95%置信区间为-16%至-46%;p<0.001),在首次多方面干预期间出现显著的趋势变化(-24单位/月,95%置信区间为-42至-7;p = 0.007)。在外展访问结束后(2004年7月),消耗量增加(+32单位/月,95%置信区间:14至50,p<0.001)。第二次干预没有显著影响。
一项复杂的干预措施(审核、反馈、外展访问)对实践产生了影响。即使在资源密集程度较低的干预之后,这种影响也未能持续。需要其他类型的干预措施,以便能够持续实施,从长期改善医嘱开具行为。